Table 2.
MRRa for all-cause, cancer-specific and other-cause death among AML CML and myeloma patients, Sweden 2002–2009
| AMLb MRR (95 % CI) | CMLc MRR (95 % CI) | Myeloma MRR (95 % CI) | |
|---|---|---|---|
| All-cause death | |||
| Comorbid disease | |||
| No | 1.00 | 1.00 | 1.00 |
| Yes | 1.39 (1.26–1.52) | 1.64 (1.34–2.01) | 1.40 (1.30–1.50) |
| No. of comorbid diseases | |||
| 0 | 1.00 | 1.00 | 1.00 |
| 1 | 1.25 (1.12–1.38) | 1.41 (1.12–1.77) | 1.29 (1.19–1.40) |
| 2+ | 1.78 (1.57–2.02) | 2.22 (1.71–2.88) | 1.67 (1.51–1.85) |
| Sex | |||
| Men | 1.00 | 1.00 | 1.00 |
| Women | 0.91 (0.84–1.00) | 0.83 (0.69–1.02) | 0.89 (0.83–0.95) |
| Education level | |||
| 0–9 | 1.00 | 1.00 | 1.00 |
| 10–12 | 0.98 (0.89–1.09) | 1.09 (0.89–1.35) | 0.97 (0.89–1.04) |
| > 12 | 0.80 (0.70–0.91) | 0.93 (0.70–1.25) | 0.83 (0.75–0.92) |
| Cancer-specific death | |||
| Comorbid disease | |||
| No | 1.00 | 1.00 | 1.00 |
| Yes | 1.27 (1.15–1.40) | 1.28 (0.96–1.70) | 1.17 (1.08–1.28) |
| No. of comorbid diseases | |||
| 0 | 1.00 | 1.00 | 1.00 |
| 1 | 1.16 (1.04–1.29) | 1.12 (0.81–1.55) | 1.12 (1.02–1.23) |
| 2+ | 1.60 (1.39–1.83) | 1.66 (1.13–2.44) | 1.31 (1.15–1.48) |
| Sex | |||
| Men | 1.00 | 1.00 | 1.00 |
| Women | 0.92 (0.84–1.01) | 0.91 (0.70–1.20) | 0.91 (0.84–0.99) |
| Education level | |||
| 0–9 | 1.00 | 1.00 | 1.00 |
| 10–12 | 0.97 (0.87–1.08) | 1.19 (0.89–1.58) | 0.96 (0.88–1.06) |
| > 12 | 0.80 (0.69–0.91) | 0.72 (0.46–1.12) | 0.87 (0.78–0.97) |
| Other-cause death | |||
| Comorbid disease | |||
| No | 1.00 | 1.00 | 1.00 |
| Yes | 2.64 (2.00–3.48) | 2.14 (1.60–2.85) | 2.22 (1.94–2.55) |
| No. of comorbid diseases | |||
| 0 | 1.00 | 1.00 | 1.00 |
| 1 | 2.22 (1.64–3.01) | 1.80 (1.30–2.49) | 1.91 (1.64–2.23) |
| 2+ | 3.86 (2.72–5.47) | 2.98 (2.07–4.30) | 3.02 (2.53–3.62) |
| Sex | |||
| Men | 1.00 | 1.00 | 1.00 |
| Women | 0.90 (0.69–1.16) | 0.76 (0.58–1.01) | 0.82 (0.72–0.94) |
| Education level | |||
| 0–9 | 1.00 | 1.00 | 1.00 |
| 10–12 | 1.07 (0.79–1.43) | 1.00 (0.73–1.36) | 0.97 (0.83–1.13) |
| > 12 | 0.85 (0.58–1.25) | 1.17 (0.80–1.73) | 0.72 (0.58–0.88) |
aMRR mortality rate ratios adjusted for age (in 10 year intervals), country of birth, time since diagnosis, calendar year of diagnosis and number of comorbid diseases, sex and education level except when main effects of these factors were estimated, statistically significant results (p<0.05) are in bold. bAML acute myeloid leukemia, cCML chronic myeloid leukemia